EGFR and glioblastoma: The assessment of LOH10q genotype is not included in the recent WHO classification for gliomas (WHO 2016), as it is believed that the assessment of both chromosome 7+/10q− and TERTp mutations is perhaps more informative than assessing EGFR amplification for the diagnosis of GBM (7).